[HTML][HTML] Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
Y Yang, F Li, L Du - Journal of Nanobiotechnology, 2024 - Springer
Nanobodies, single-domain antibodies derived from variable domain of camelid or shark
heavy-chain antibodies, have unique properties with small size, strong binding affinity, easy …
heavy-chain antibodies, have unique properties with small size, strong binding affinity, easy …
[PDF][PDF] Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
Y Yang, F Li, L Du - 2024 - scienceopen.com
Background Coronaviruses (CoVs) are a large group of viruses belonging to the
Orthocoronavirinae subfamily (family, Coronaviridae; order, Nidovirales), which cause …
Orthocoronavirinae subfamily (family, Coronaviridae; order, Nidovirales), which cause …
[HTML][HTML] Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
Y Yang, F Li, L Du - Journal of Nanobiotechnology, 2024 - ncbi.nlm.nih.gov
Nanobodies, single-domain antibodies derived from variable domain of camelid or shark
heavy-chain antibodies, have unique properties with small size, strong binding affinity, easy …
heavy-chain antibodies, have unique properties with small size, strong binding affinity, easy …
Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses.
Y Yang, F Li, L Du - Journal of Nanobiotechnology, 2024 - europepmc.org
Nanobodies, single-domain antibodies derived from variable domain of camelid or shark
heavy-chain antibodies, have unique properties with small size, strong binding affinity, easy …
heavy-chain antibodies, have unique properties with small size, strong binding affinity, easy …
Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses.
Y Yang, F Li, L Du - Journal of Nanobiotechnology, 2024 - search.ebscohost.com
Nanobodies, single-domain antibodies derived from variable domain of camelid or shark
heavy-chain antibodies, have unique properties with small size, strong binding affinity, easy …
heavy-chain antibodies, have unique properties with small size, strong binding affinity, easy …
[HTML][HTML] Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
Y Yang, F Li, L Du - Journal of …, 2024 - jnanobiotechnology.biomedcentral …
Nanobodies, single-domain antibodies derived from variable domain of camelid or shark
heavy-chain antibodies, have unique properties with small size, strong binding affinity, easy …
heavy-chain antibodies, have unique properties with small size, strong binding affinity, easy …
Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
Y Yang, F Li, L Du - Journal of nanobiotechnology, 2024 - pubmed.ncbi.nlm.nih.gov
Nanobodies, single-domain antibodies derived from variable domain of camelid or shark
heavy-chain antibodies, have unique properties with small size, strong binding affinity, easy …
heavy-chain antibodies, have unique properties with small size, strong binding affinity, easy …
[PDF][PDF] Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
Y Yang, F Li, L Du - 2024 - jnanobiotechnology.biomedcentral …
Background Coronaviruses (CoVs) are a large group of viruses belonging to the
Orthocoronavirinae subfamily (family, Coronaviridae; order, Nidovirales), which cause …
Orthocoronavirinae subfamily (family, Coronaviridae; order, Nidovirales), which cause …